Home
ImmuneHealth-4-All First Call Update
Earlier this year, we officially opened our first funding call, an important milestone for the ImmuneHealth-4-All programme. This call is specifically designed to take promising results from previous ImmuneHealthXL projects and translate them further towards real patient impact.
The call is structured in two stages, and we've just passed an exciting first milestone: the pre-proposal deadline closed in late April. We're pleased to share that 7 public-private consortia submitted a pre-proposal from across the Netherlands!
We are pleased with a wide range of proposals focused on disease-overarching research, covering a wide range of Immune Mediated Inflammatory Diseases (IMIDs), such as Inflammatory Bowel Disease, Multiple Sclerosis, Rheumatoid Arthritis, Vasculitis, and Necrotizing Myopathy.
We are encouraged by the strong response and the diversity of research directions represented. All projects passed the eligibility check and will now proceed to further detail their research plans. Next up is the review and discussion with the Patient Representative Panel which plays a critical role in our review process.
Stay tuned for more updates as the programme progresses!